Hospital
Riverside Medical Center
Riverside Medical Center was paid $3.72M by Medicaid between Jan 2018 and Jul 2020, across 116 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 72% of everything it billed.
33Billing provider infoRIVERSIDE MEDICAL CENTER
KANKAKEE, IL 60901
KANKAKEE, IL 60901
33aNPI1538208210assigned 02/06/2007
33bProvider typeRehabilitation Hospital Unit
28Total paid$3.72M
24GClaims146,091
24DCodes billed116
24AFirst – last monthJan 2018 – Jul 2020
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,990 | $1.14M | |
| 2019 | 70,579 | $1.66M | |
| 2020 | 33,522 | $917K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 72% | 31,324 | 4,139 | $2.66M |
| 97162 | 4.4% | 1,616 | 900 | $164K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.3% | 1,480 | 1,181 | $86K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.3% | 1,568 | 1,304 | $86K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.1% | 4,330 | 3,171 | $77K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.1% | 4,320 | 3,159 | $77K |
| 97161 | 1.9% | 801 | 412 | $72K | |
| 97163 | 1.4% | 449 | 295 | $51K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 6,438 | 5,333 | $41K |
| 80053 | Comprehensive metabolic panel | 1.1% | 10,782 | 8,335 | $40K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,891 | 335 | $30K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,219 | 1,626 | $27K |
104 more codes
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 3,163 | $24K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,160 | $23K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,828 | $18K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,542 | $15K |
| 87088 | <1% | 3,208 | $13K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 621 | $12K |
| 80061 | Lipid panel | <1% | 5,606 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 972 | $9K |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 962 | $9K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,706 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,740 | $8K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 281 | $8K |
| 87070 | <1% | 2,877 | $7K | |
| 82607 | <1% | 1,454 | $6K | |
| 73630 | <1% | 551 | $6K | |
| 86003 | <1% | 342 | $6K | |
| 84439 | <1% | 2,184 | $6K | |
| 86780 | <1% | 1,061 | $5K | |
| 87186 | <1% | 1,059 | $5K | |
| 86038 | <1% | 695 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,288 | $4K |
| 86225 | <1% | 799 | $3K | |
| 82746 | <1% | 848 | $3K | |
| 80055 | <1% | 318 | $3K | |
| 72110 | <1% | 181 | $3K | |
| G0433 | Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening | <1% | 733 | $3K |
| 73610 | <1% | 167 | $3K | |
| 82570 | <1% | 1,622 | $3K | |
| 85610 | <1% | 1,585 | $3K | |
| 87077 | <1% | 1,535 | $3K | |
| 81001 | <1% | 2,407 | $2K | |
| 83970 | <1% | 168 | $2K | |
| 83550 | <1% | 792 | $2K | |
| 82728 | <1% | 1,005 | $2K | |
| 87340 | <1% | 567 | $2K | |
| 80074 | <1% | 205 | $2K | |
| 74018 | <1% | 229 | $2K | |
| 87081 | <1% | 865 | $2K | |
| 73130 | <1% | 233 | $2K | |
| 85027 | <1% | 938 | $2K | |
| 82043 | <1% | 1,439 | $2K | |
| 80076 | <1% | 556 | $2K | |
| 80306 | <1% | 354 | $2K | |
| 73564 | <1% | 142 | $2K | |
| 83655 | <1% | 179 | $2K | |
| 86140 | <1% | 901 | $2K | |
| 73030 | <1% | 118 | $1K | |
| 86850 | <1% | 864 | $1K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 191 | $1K |
| 86901 | <1% | 1,013 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 109 | $1K |
| 84481 | <1% | 332 | $1K | |
| 86787 | <1% | 199 | $1K | |
| 83516 | <1% | 229 | $1K | |
| 80069 | <1% | 347 | $1K | |
| 85652 | <1% | 1,277 | $1K | |
| 72100 | <1% | 93 | $1K | |
| 83735 | <1% | 694 | $1K | |
| 86762 | <1% | 557 | $1K | |
| 82950 | <1% | 738 | $1K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 325 | $1K |
| 83540 | <1% | 529 | $1K | |
| 84702 | <1% | 267 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 53 | $1K |
| 86900 | <1% | 881 | $907.59 | |
| 80164 | <1% | 291 | $883.93 | |
| 86430 | <1% | 330 | $777.51 | |
| 72114 | <1% | 27 | $739.55 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 98 | $725.77 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 115 | $717.87 |
| 87493 | <1% | 34 | $715.77 | |
| 72050 | <1% | 35 | $598.82 | |
| 82951 | <1% | 102 | $541.23 | |
| 86747 | <1% | 18 | $495.84 | |
| 84403 | <1% | 26 | $456.12 | |
| 86706 | <1% | 49 | $435.85 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 67 | $422.88 |
| 82784 | <1% | 104 | $396.40 | |
| 86618 | <1% | 37 | $338.12 | |
| 83525 | <1% | 38 | $284.47 | |
| 84550 | <1% | 184 | $280.49 | |
| 97166 | <1% | 25 | $278.06 | |
| 85730 | <1% | 121 | $251.24 | |
| 82247 | <1% | 121 | $248.45 | |
| 87045 | <1% | 54 | $241.24 | |
| 86704 | <1% | 17 | $235.24 | |
| 81003 | <1% | 298 | $232.56 | |
| 87280 | <1% | 34 | $213.92 | |
| 83001 | <1% | 24 | $206.57 | |
| 82952 | <1% | 89 | $185.16 | |
| 87210 | <1% | 109 | $174.89 | |
| 84146 | <1% | 34 | $158.88 | |
| 86200 | <1% | 35 | $152.91 | |
| 72072 | <1% | 15 | $124.03 | |
| 82248 | <1% | 77 | $93.14 | |
| 83002 | <1% | 23 | $83.33 | |
| 84100 | <1% | 92 | $77.54 | |
| 83690 | <1% | 45 | $66.03 | |
| 85045 | <1% | 64 | $60.96 | |
| 84156 | <1% | 58 | $43.68 | |
| 84480 | <1% | 14 | $36.39 | |
| 83615 | <1% | 30 | $34.80 | |
| 87106 | <1% | 38 | $32.86 | |
| 88142 | <1% | 17 | $29.56 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOUGLAS, BILL (VICE PRESIDENT AND CFO)
| Provider | Location | Paid |
|---|---|---|
| Riverside Medical Center | Kankakee, IL | $1.59M |
| Riverside Medical Center | Peotone, IL | $1.17M |
| Riverside Medical Center | Kankakee, IL | $245K |
| Riverside Medical Center | Kankakee, IL | $104K |
| Riverside Medical Center | Kankakee, IL | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.